Reducing bloodstream infections from central lines
Part of Infections clinical trials.
This study aims to reduce infections that can happen when you have a central line, a special tube placed in a large vein to give medicines or fluids. Participating may help improve safety for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are not in hospice care.
- You have a central line in place for at least 24 hours.
- You do not have a central line that has been in place for less than 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is about finding how common bloodstream infections are in people with central lines (a special IV for long-term medicines). It will help doctors learn how to prevent these infections.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This trial tests a new catheter lock solution (DefenCath) to prevent infections in people who need long-term IV nutrition through a central line. It compares the study drug to a standard heparin lock, and you'll be randomly assigned to one group.
This trial tests whether using a special skin/line “tissue glue” around IV line sites can lower the risk of bloodstream infections in critically ill children with heart disease. It may help reduce infection rates and line-related complications in children considered high risk.
Hear when a new Central Line-associated Bloodstream Infection (CLABSI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.